Therapeutic Modulation of T Follicular Helper Cells by Low-Dose IL-2 Treatment

Methods Mol Biol. 2022:2380:255-265. doi: 10.1007/978-1-0716-1736-6_21.

Abstract

T follicular helper (Tfh) cells are a subset of specialized CD4+ T cell residing in B cell follicles and confer essential support for germinal center responses, which lead to the generation of long-lived humoral immunity. A great deal of evidence from the past 15 years indicate that excessive differentiation and dysregulated function of Tfh cells often promote autoimmunity by inducing autoantibody production. Interleukin-2 was identified as a major suppressor to inhibit Tfh differentiation. Therefore, IL-2 treatment was applied in suppressing Tfh function in mouse models and more recently in a clinical trial of patients with systemic lupus erythematosus. Here we describe a protocol for low-dose IL-2 treatment in a murine immunization model and on the assessment of the suppression of Tfh response using flow cytometry.

Keywords: Autoimmunity; Flow cytometry; Germinal center; Low-dose IL-2 treatment; T follicular helper cells.

MeSH terms

  • Animals
  • Autoimmunity
  • B-Lymphocytes
  • Cell Differentiation
  • Germinal Center
  • Humans
  • Interleukin-2
  • Mice
  • T Follicular Helper Cells*
  • T-Lymphocytes, Helper-Inducer

Substances

  • Interleukin-2